1073例热毒宁注射液临床用药帕累托图及鱼骨图分析

doi:10.19803/j.1672-8629.2020.10.21

摘要/Abstract

摘要： 目的通过对我院热毒宁注射液的用药合理性及药品不良反应情况进行分析,为儿童合理应用热毒宁注射液提供参考。方法抽取我院2017年12月至2018年11月儿童应用热毒宁注射液的1 073例病例,应用帕累托图对用药不合理因素进行分析,应用鱼骨图对药品不良反应（ADR）根因进行分析。结果儿童使用热毒宁注射液的1 073例病例中有532例（49.58%）存在不合理用药的情况。其中超适应证（56.58%）和超疗程用药（24.25%）为其主要因素,次要因素为未辨证用药（12.22%）。1 073份病例中,发生ADR的共22例,发生率为2.05%;ADR的发生与超适应证、超疗程用药、静脉用药浓度和滴速、患者自身等因素有关;其中,超适应证用药引起的ADR占59.09%,超疗程用药引起的ADR占31.82%。结论该院热毒宁注射液临床用药存在一定不合理性,医院可依据不合理用药的主要因素、次要因素以及药品不良反应风险因素加强中药注射剂合理用药的信息化,实时监测及干预,进行重点监控,促进中药注射剂的合理使用水平,提高儿童用药的安全性。

关键词: 热毒宁注射液, 帕累托图, 鱼骨图, 合理用药, 药品不良反应

Abstract: Objective To analyze the rationality of clinical use of Reduning injection and consequent adverse drug reactions in our hospital in order to provide reference for the rational use of Reduning injection in children. Methods Data on all the cases of children who received Reduning injection in our hospital between December 2017 and November 2018 was retrieved, and a total of 1073 cases were selected. Adverse drug reactions were analyzed using Pareto charts and fishbone diagrams. Results Improper medication was found in 532 (49.58 %) of the 1073 cases who used Reduning injection. of which off-labeled use (56.58 %) and over-course of treatment (24.25 %) were the leading factors. The secondary factor was undifferentiated medication(12.22 %). ADR occurred in 22 of the 1 073 cases, accounting for 2.05 % and related to off-labeled use, beyond-the-course medication , intravenous drug concentration and drip rate, and patients themselves. 59.09 % of the adverse reactions were caused by off-labeled use and 31.82 % by beyond-the-course treatment. Conclusion There is something irrational about the way Reduning injection is used in our hospital. The hospital can strengthen the real-time monitoring and intervention of the use of TCM injections with the risk factors in mind.

Key words: Reduning injection, pareto chart, fishbone diagram, rational use of medicine, adverse drug reaction（ADR）

中图分类号:

R286

吕天益, 匡丽, 陈明颖. 1073例热毒宁注射液临床用药帕累托图及鱼骨图分析[J]. 中国药物警戒, 2020, 17(10): 745-748.

LYU Tianyi, KUANG Li, CHEN Mingying. Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.

参考文献

[1] Li YX.Current situation and Development Strategy of Chinese patent medicine market for children in China[J]. Chinese Prescription Medicine(中国处方药), 2018,16(2):28-30.
[2] Li HB,Yu Y,Wang ZZ,et al.Research on chemical constituents from Reduning Injection(Ⅲ)[J]. Chinese Traditional and Herbal Drugs(中草药),2016,47(10):1643-1649.
[3] Sun L, Zhou J, Wang ZZ.Pharmacological action and clinical research progress of Reduning injection[J]. Journal of Emergency in Traditional Chinese Medicine(中国中医急症),2014,23(12):2247-2249.
[4] Ge W, Li HB, Yu Y, et al.Research progress on chemical constituents, pharmacological action,and clinical application of Reduning Injection[J]. Chinese Traditional and Herbal Drugs(中草药),2017, 48(5):1027-1036.
[5] Li XH,Li SJ,Wen T, et al.Evaluation of clinical efficacy of Reduning Injection in treating severe Hand-foot-mouth Disease in children[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2014,29(2):362-365.
[6] Wang X,Xu J,Xu J, et al.Systematic Review of Reduning Injection in Treatment of Hand-foot-mouth Disease[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2016,22(19):171-176.
[7] Huang WX, QY, Yuan SW.A randomized controlled trial of Reduning Injection in the treatment of pediatric Hand-foot-mouth Disease[J]. Chinese Traditional Patent Medicine(中成药), 2014, 36(7):1565-1567.
[8] Shi XJ.Clinical observation on 32 cases of mycoplasma pneumonia in children treated with Reduning Injection as an adjuvant therapy[J]. Journal of Pediatrics of Traditional Chinese Medicine(中医儿科杂志), 2018,14(3):33-36.
[9] Huang XY,Duan XJ,Wu JR, et al.Meta-analysis of Reduning Injection in Treatment of Community-acquired Pneumonia[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2018,27(9):573-581.
[10] Dong BB, Zhao PQ, Jia W, et al.Correlation of Neutrophil-to-lymphcyte Ratio (NLR) and C-reactive Protein (CRP) in Treating Hospital- acquired Pneumonia (HAP) Patients with Reduning Injection before and after Therapy[J]. Journal of Yunnan University of Traditional Chinese Medicine(云南中医学院学报),2017,40(5): 40-43.
[11] Zhang WY, Analysis of the characteristics and risk factors of adverse reactions of Reduning injection in children population[J]. Journal of China Prescription Drug(中国处方药), 2017,15(12):66-67.
[12] Wang YT, The present situation, problems and countermeasures of children's drug use in China[D]. Beijing: Beijing University of Chinese Medicine,2018.
[13] Shi J.Clinical Analysis of 120 Cases Children Ocular Trauma[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology(中国斜视与小儿眼科杂志),2016,24( 4) : 40-42.
[14] Chen LM,He XY,Huang J S, et al.Analysis of the effectiveness of the key monitoring and management of traditional Chinese medicine injections in one hospital[J]. Journal of Guangdong Pharmaceutical University(广东药科大学学报), 2019,35(1):116-119.
[15] Luo XC.Pharmacological Effect, Clinical Application and Adverse Reaction of Reduning Injection[J]. Chinese Journal of Pharmaco- vigilance(中国药物警戒), 2013,10(4):215-218.
[16] Yan L,Zeng MG,Zheng QQ, et al.Analysis of unreasonable application of traditional Chinese medicine injections in a hospital in 2015[J]. Strait Pharmaceutical Journal(海峡药学), 2018,30(5): 256-260.
[17] Cao C,Wen XL,Lin WH, et al.Analysis on 2621 cases of adverse drug reaction reports by Fishbone and Pareto diagram[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2018,36(1):88-92.
[18] Wang X,Xu J,Xu J, et al.Logistic Regression Analysis of Influential Factors of ADR Induced by Reduning Injection[J].China Pharm(中国药房), 2017,28(2):194-197.
[19] Wang D,Peng LL,Liu CL, et al.Analysis of Pharmocovigilance and Difference with the ADR Monitoring in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017,14(3):150- 152-157.